Treating erectile dysfunction after radical radiotherapy and androgen deprivation therapy (ADT) for prostate cancer
Prostate Cancer UK and Macmillan Cancer Support
Radiotherapy and androgen deprivation therapy for prostate cancer can induce structural changes in the penile tissue leading to delayed (for up to two years) or progressive erectile dysfunction. Erectile dysfunction (ED) affects up to 85% of men receiving ADT, and a similar number of men after radiotherapy. Early patient education and intervention is necessary to reduce the impact of ED on men and their partners.
This Guidelines summary covers assessment, predictive factors for recovery, and includes a useful treatment pathway.